Mujahed Ahmed
Internal Medicine · Palm Springs, FLNPI 1639121833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,224 and has fallen 95.4% since, to $56 in 2023.
Across 209 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$677
- AstraZeneca$440
- Novo Nordisk$365
- Lilly USA, LLC$349
- Pfizer$302
- Boehringer Ingelheim$165
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,543100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $677 |
| AstraZeneca | 25 | $440 |
| Novo Nordisk | 22 | $365 |
| Lilly USA, LLC | 21 | $349 |
| Pfizer | 17 | $302 |
| Boehringer Ingelheim | 9 | $165 |
| Kowa Pharmaceuticals America, Inc. | 8 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Astellas Pharma US Inc | 6 | $115 |
| GSK | 8 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $112 |
| Amgen | 6 | $107 |
| Arbor Pharmaceuticals, Inc. | 5 | $79 |
| Abbott | 4 | $71 |
| Eisai Inc. | 4 | $60 |
| Bayer | 2 | $53 |
| Nevro Corp. | 2 | $48 |
| Gilead | 3 | $45 |
| Amarin Pharma, Inc. | 2 | $37 |
| Novartis | 2 | $35 |
| Aytu Biopharma, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Merck | 1 | $13 |
How this compares
$3,543 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Palm Springs
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.